Initially there was no specific way to reverse okay like okay well so um you know so the anticoagulant effect of dabigatran in the event of so so well okay like uh like well a major bleeding event, unlike for warfarin, but a dabigatran antidote (idarucizumab) was approved by the FDA in 2015.